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Previewsof phosphorylated STAT3 in GSCs. Sub-
stantial additional research is required to
determine if this early experimental suc-
cess will translate into notable clinical
response.
The findings of Kim et al. (2013) are
important, because they establish an
H3K27-independent role for EZH2 in
GBM through K180 trimethylation of
STAT3, which appears to be involved in
the aggressiveness of high-grade glioma
(Figure 1). Furthermore, the results pro-
vide a new understanding of regulatory
pathways that drive GSC phenotypes. If
these findings are relevant to cancer
stem cells in patients, STAT3 and/or
EZH2 will become even more attractive
targets for improving therapeutic re-
sponse and patient survival.REFERENCES
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There is much interest in defining the nutrient dependencies of cancer cells and their mechanisms of adap-
tation to nutrient depletion. In a recent issue of Cell, Leprivier and colleagues demonstrate that eEF2K, which
can inhibit translation elongation acutely during protein synthesis, is a critical switch in the survival versus
death fate of starved cancer cells.Cells and organisms have evolved exqui-
site mechanisms to acutely adapt to
fluctuations in nutrient availability. Star-
vation impinges on highly conserved
nutrient-sensing pathways, resulting in
an integrated and adaptive response
that includes an abrupt halt to
anabolic processes that consume nutri-
ents and energy. The mammalian target
of rapamycin complex 1 (mTORC1),
general amino acid control nonderepres-
sible 2 (GCN2), and AMP-dependent
protein kinase (AMPK) are the best
characterized of these nutrient sensors
(Yuan et al., 2013), all of which exert
acute control over protein synthesis
(Figure 1A), perhaps the most nutrient-and energy-costly of cellular processes.
It is now evident that cancer cells can
drive anabolic processes that promote
cell growth and proliferation in a manner
largely independent of normal growth
signals (Cantor and Sabatini, 2012).
Importantly, oncogenic events that
disconnect anabolic processes from
normal control mechanisms are likely
to render tumor cells more vulnerable
to the loss of specific nutrients. In a
recent study published in Cell, Leprivier
et al. (2013) find that the adaptation of
tumor cells to nutrient deprivation is
dependent on their ability to acutely
block translation elongation during pro-
tein synthesis.In an isogenic fibroblast model, Lepriv-
ier et al. (2013) found that oncogene-
transformed cells were much more
sensitive to severe nutrient depletion in
the form of complete removal of glucose,
amino acids, and serum. Surprisingly,
this susceptibility was not due to in-
creased ATP consumption as, unlike
nontransformed cells, the oncogene-
expressing cells somehow sustained
their ATP levels in the absence of nutri-
ents. This difference was also reflected
in a lack of activation of AMPK, which
is normally stimulated in response to
energy stress (defined as an increase
in the ratio of cellular AMP or ADP to
ATP) and plays a critical role in23, June 10, 2013 ª2013 Elsevier Inc. 713
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Figure 1. Model of the Adaptive Regulation of mRNA Translation in
Response to Starvation in Normal and Transformed Cells
(A) Starvation regulates downstream kinases to acutely inhibit mRNA transla-
tion initiation and elongation. In response to starvation, GCN2 is activated to
inhibit eIF2a, and mTORC1 and S6K are inhibited to block their promotion
of translation initiation through downstream targets, including those that affect
assembly of the eIF4F complex. Starvation also activates AMPK, which in-
hibits mTORC1 and activates eEF2K, which inhibits translation elongation
by blocking the function of eEF2. Translation elongation consumes amino
acids (AA) and ATP.
(B) Oncogenic transformation can attenuate AMPK activation or lead to
other events, resulting in a defect in the proper activation of eEF2K in
response to starvation. This defect results in sustained translation elongation
under starvation conditions, which triggers cell death through an unknown
mechanism.
(C) Restoring the response of eEF2K to starvation results in inhibition of eEF2,
thereby stalling the translating ribosome and blocking elongation. This acute
adaptive response protects cells from starvation-induced death.
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Previewsadaptation to nutrient deple-
tion (Shackelford and Shaw,
2009). AMPK phosphorylates
numerous targets aimed at
alleviating energy stress by
promoting catabolic pro-
cesses and inhibiting
anabolic processes. A major
mechanism of AMPK-medi-
ated inhibition of anabolic
processes is to block
mTORC1 signaling, which is
also inhibited by starvation
through AMPK-independent
pathways (Yuan et al.,
2013). mTORC1 stimulates
protein synthesis, primarily
at the level of translation initi-
ation, and an inability to
inhibit mTORC1 can sensitize
cells to nutrient starvation
(Choo et al., 2010). However,
Leprivier et al. (2013) found
that mTORC1 signaling is
properly attenuated under
starvation in both normal
and transformed cells in their
system, reflected in blocked
mRNA translation initiation
and decreased global protein
synthesis.
In contrast to mTORC1,
another downstream target
of AMPK that regulates
mRNA translation the eukary-
otic elongation factor 2 (eEF2)
kinase (eEF2K) was found to
be differentially regulated in
normal and transformed cells
(Leprivier et al., 2013). AMPK
is thought to activate eEF2K
by direct phosphorylation of
S398 (Browne et al., 2004),
which lies within an atypi-
cal AMPK phosphorylation
sequence (Shackelford andShaw, 2009). Activated eEF2K
phosphorylates eEF2 on T56 to inhibit
its function in translation elongation
(Figure 1A). Importantly, Leprivier et al.
(2013) found a pronounced difference in
the inhibitory phosphorylation of eEF2-
T56 in response to nutrient deprivation
in the normal and transformed cells,
with the latter displaying greatly reduced
levels. Despite blocked translation initia-
tion in both settings, loss of proper
control over eEF2 in transformed cells
resulted in continued elongation on714 Cancer Cell 23, June 10, 2013 ª2013 ElsmRNAs that had already initiated trans-
lation, with ribosomes ultimately running
off of those transcripts (Figure 1B). In
contrast, normal cells, and transformed
cells adapted to starvation, display
proper eEF2K activation and eEF2 inhibi-
tion, resulting in an acute block in transla-
tion elongation in response to starvation,
reflected in stalled ribosomes on bound
transcripts (Figure 1C).
Acute inhibition of translation elonga-
tion by AMPK-mediated eEF2K activa-
tion was found to be essential for theevier Inc.survival of both normal and
transformed cells in response
to nutrient deprivation (Lep-
rivier et al., 2013). A defect in
triggering this adaptive
response appears to be ama-
jor mechanism by which
some cancer cells display
enhanced sensitivity to star-
vation (Figures 1B and 1C).
Cancer cells with defects in
AMPK activation will be
particularly susceptible to
nutrient deprivation. The
most frequent genetic event
in human cancers known to
lead to strong attenuation
of AMPK signaling is the
loss of the tumor sup-
pressor LKB1, which acti-
vates AMPK in response to
energy stress (Shackelford
and Shaw, 2009). Interest-
ingly, LKB1-deficient tumors
are sensitized to energy
stress-inducing agents (e.g.,
phenformin) (Shackelford
et al., 2013), suggesting that
loss of control over eEF2K
along with other established
AMPK targets might underlie
this susceptibility. In the
study by Leprivier et al.
(2013), oncogene introduc-
tion yielded transformed cells
where nutrient deprivation
failed to cause the type of
energy stress that normally
activates AMPK. How ATP
levels are sustained under
starvation conditions in these
transformed cells is a key
question for understanding
the nature of this adaptive
response. Also, transforming
events leading to aberrantactivation of mTORC1 or ERK signaling
could chronically block eEF2K function
independent of effects on AMPK,
because the respective downstream ki-
nases S6K and RSK can phosphorylate
and inhibit eEF2K (Proud, 2007).
Upon starvation, eEF2K is transcrip-
tionally upregulated in mammalian cells
and Caenorhabditis elegans, and there is
an evolutionarily conserved requirement
for eEF2K for survival under such condi-
tions (Leprivier et al., 2013). Elevated
eEF2K transcript levels correlated with
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Previewsincreased tumor grade and decreased
patient survival in glioma, suggesting
that increased eEF2K might promote tu-
mor cell survival, perhaps by providing
protection from nutrient deprivation.
While still a poorly defined area of tumor
biology, tumor cells are believed to expe-
rience intermittent availability of specific
nutrients during the course of tumor pro-
gression due to insufficient or aberrant
vasculature feeding the tumor. Therefore,
the observed increase in eEF2K expres-
sion in glioma may be an adaptive
response to fluctuating nutrients in the tu-
mor microenvironment, especially in
advanced tumors. Another question is
whether the tumor microenvironment
ever experiences extreme levels of
nutrient starvation approaching those
levels typically used in cell culture experi-
ments. Interestingly, Leprivier et al. (2013)
demonstrate that xenograft tumors from
cells overexpressing eEF2K, while greatly
reduced in size, are resistant to the
growth inhibitory effects of calorie restric-
tion. Reciprocally, eEF2K null tumors dis-
played increased necrosis and apoptosis
under calorie restriction, whereas their
growth was indistinguishable from wild-
type tumors in mice fed a normal diet.
Therefore, these findings provide another
example whereby tumor cell-intrinsicnutrient-sensing pathways act in concert
with the nutritional status of the host to in-
fluence tumor growth (Kalaany and Saba-
tini, 2009). However, as circulating
glucose levels are only marginally
affected by calorie restriction, this
response is likely to reflect changes in
both local and systemic (insulin and
IGF1) nutrient signals.
Other key questions remain. How does
sustained translation elongation kill
nutrient-deprived cells when translation
initiation is appropriately inhibited? The
signal stimulating cell death must
emanate from a specific form of stress,
or perhaps a selected class of proteins,
produced by sustained translation elon-
gation in the absence of exogenous nutri-
ents. Would pharmacological inhibitors to
eEF2K, alone or in combination with other
compounds, be effective cancer treat-
ments? Intriguingly, reducing eEF2K
expression has been shown to sensitize
glioma cells to the glucose analog 2-de-
oxyglucose (Wu et al., 2009). Whereas
the dependence on eEF2K under
nutrient-deplete conditions is not specific
to tumor cells, it might be particularly
important in the context of the tumor
microenvironment. eEF2K joins a growing
list of adaptive responses to starvation
(including the regulation of AMPK,Cancer CellmTORC1, and autophagy), which, due to
defective control in tumor cells, could
represent a vulnerability and a therapeutic
opportunity.REFERENCES
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The scaffold protein IQGAP1 regulates cell signaling through the RAF/MEK/ERK pathway. Recent data show
that cancer cells in which the RAF/MEK/ERK pathway is activated are particularly sensitive to the disruption
of IQGAP1 function. IQGAP drugs may be particularly effective in tumors that develop resistance to existing
pathway drugs.The receptor tyrosine kinase (RTK)/RAS/
RAF/MEK/ERK pathway drives prolifera-
tion, survival, invasion, and metastasis in
human cancer. Antibodies that bind to
the extracellular domains of RTKs or small
molecule inhibitors that block RTK kinase
activity are effective in a variety of cancersif the patients are appropriately selected.
More recently, it has been shown that
drugs that target BRAF and MEK are
effective in melanoma patients whose tu-
mors carry BRAF mutations (Catalanotti
et al., 2013; Chapman et al., 2011; Falc-
hook et al., 2012; Flaherty et al., 2010,2012; Hauschild et al., 2012). Thus, this
pathway is a validated therapeutic target
in cancer, and its protein kinases, in
particular, have been shown to be trac-
table therapeutic targets.
In contrast to kinases, the RAS small
G-proteins appear to be intractable23, June 10, 2013 ª2013 Elsevier Inc. 715
